Correlation Between Icosavax and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Icosavax and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Monopar Therapeutics, you can compare the effects of market volatilities on Icosavax and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Monopar Therapeutics.
Diversification Opportunities for Icosavax and Monopar Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Icosavax and Monopar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Icosavax and Monopar Therapeutics
Given the investment horizon of 90 days Icosavax is expected to generate 56.54 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Icosavax is 4.73 times less risky than Monopar Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,830 in Monopar Therapeutics on November 2, 2024 and sell it today you would earn a total of 2,420 from holding Monopar Therapeutics or generate 132.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Icosavax vs. Monopar Therapeutics
Performance |
| Timeline |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Monopar Therapeutics |
Icosavax and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icosavax and Monopar Therapeutics
The main advantage of trading using opposite Icosavax and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |